Given that ALG2 is one of the fourteen genes implicated in Congenital Myasthenic Syndrome, a deeper understanding of tissue-specific pathophysiology may help link clinical manifestations to ocular involvement in CDG patients. The gene discussed is ALG2; the disease is congenital myasthenic syndrome.